Search for persons
X
?
1
Safety, tolerability, and immunogenicity of inactivated pol..:
Erdem, Rahsan ; De Coster, Ilse ; Withanage, Kanchanamala...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996288/. , 2023
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996288/. , 2023
?
2
Safety and immunogenicity of intramuscularly administered C..:
Lee, Tida ; Gutiérrez, Ramiro L ; Maciel, Milton...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461560/. , 2021
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461560/. , 2021
?
4
A Phase 2a randomized, single-center, double-blind, placebo..:
Rahsan Erdem ; Gwen Ambler ; Mohamed Al-Ibrahim...
https://doi.org/10.1371/journal.pntd.0009969. , 2021
https://doi.org/10.1371/journal.pntd.0009969. , 2021
?
5
Supporting information:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/journal_contribution/Supporting_information_/17045387. , 2021
https://figshare.com/articles/journal_contribution/Supporting_information_/17045387. , 2021
?
6
Grading of stool consistency and diarrhea severity:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/dataset/Grading_of_stool_consistency_and_diarrhea_severity_/17045483. , 2021
https://figshare.com/articles/dataset/Grading_of_stool_consistency_and_diarrhea_severity_/17045483. , 2021
?
7
Secondary efficacy endpoints for the modified intent-to-tre..:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/dataset/Secondary_efficacy_endpoints_for_the_modified_intent-to-treat_population_/17045501. , 2021
https://figshare.com/articles/dataset/Secondary_efficacy_endpoints_for_the_modified_intent-to-treat_population_/17045501. , 2021
?
8
Study drug–related treatment-emergent adverse events by sys..:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/dataset/Study_drug_related_treatment-emergent_adverse_events_by_system_organ_class_and_preferred_term_in_the_safety_population_/17045492. , 2021
https://figshare.com/articles/dataset/Study_drug_related_treatment-emergent_adverse_events_by_system_organ_class_and_preferred_term_in_the_safety_population_/17045492. , 2021
?
9
Consolidated Standards for Reporting of Trials flow diagram:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/figure/Consolidated_Standards_for_Reporting_of_Trials_flow_diagram_/17045465. , 2021
https://figshare.com/articles/figure/Consolidated_Standards_for_Reporting_of_Trials_flow_diagram_/17045465. , 2021
?
10
Cumulative diarrhea stool volume for all subjects:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/journal_contribution/Cumulative_diarrhea_stool_volume_for_all_subjects_/17045414. , 2021
https://figshare.com/articles/journal_contribution/Cumulative_diarrhea_stool_volume_for_all_subjects_/17045414. , 2021
?
11
Source data for Fig 1:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/dataset/Source_data_for_Fig_1_/17045438. , 2021
https://figshare.com/articles/dataset/Source_data_for_Fig_1_/17045438. , 2021
?
12
Treatment-emergent adverse events by preferred term reporte..:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/journal_contribution/Treatment-emergent_adverse_events_by_preferred_term_reported_in_more_than_one_participant_5_in_any_treatment_group_in_the_safety_population_/17045408. , 2021
https://figshare.com/articles/journal_contribution/Treatment-emergent_adverse_events_by_preferred_term_reported_in_more_than_one_participant_5_in_any_treatment_group_in_the_safety_population_/17045408. , 2021
?
13
Scatterplot of iOWH032 plasma concentrations versus diarrhe..:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/figure/Scatterplot_of_iOWH032_plasma_concentrations_versus_diarrheal_stool_output_rate_/17045477. , 2021
https://figshare.com/articles/figure/Scatterplot_of_iOWH032_plasma_concentrations_versus_diarrheal_stool_output_rate_/17045477. , 2021
?
14
iOWH032 inhibits cholera toxin-induced fecal output in a ce..:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/figure/iOWH032_inhibits_cholera_toxin-induced_fecal_output_in_a_cecectomized_rat_model_/17045399. , 2021
https://figshare.com/articles/figure/iOWH032_inhibits_cholera_toxin-induced_fecal_output_in_a_cecectomized_rat_model_/17045399. , 2021
?
15
Diarrheal stool output rate overall and by blood type statu..:
Rahsan Erdem (11726357) ; Gwen Ambler (476523) ; Mohamed Al-Ibrahim (11726360)...
https://figshare.com/articles/dataset/Diarrheal_stool_output_rate_overall_and_by_blood_type_status_in_the_modified_intent-to-treat_population_/17045495. , 2021
https://figshare.com/articles/dataset/Diarrheal_stool_output_rate_overall_and_by_blood_type_status_in_the_modified_intent-to-treat_population_/17045495. , 2021